Top

Published in:

01-10-2005

Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia

Authors: S. Agarwal, G. Deshpande, D. Agarwal, A. Dave, J.J. Shah

Published in: Pediatric Cardiology | Issue 5/2005

Abstract

We describe a 6-day-old male who developed cardiac arrest due to hyperkalemia secondary to congenital adrenal hyperplasia and was successfully resuscitated. This case illustrates the importance of considering congenital adrenal hyperplasia as one of the causes of sudden cardiac arrest in a neonate. A literature review revealed only one similar case in a 3 -month-old with a fatal outcome.

Al-Alwan I, Navarro O, Daneman D, Daneman A (1999) Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia. J Pediatr 135:71PubMed

Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology (2002) J Clin Endocrinol Metab 87:4048

Gueux B, Fiet J, Couillin P (1988) Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxyeortisol and 17-hydroxyprogesterone in amniotic fluid. J Clin Endocrinol Metab 66:534PubMed

Miller WL (1994) Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78:241PubMedCrossRef

Mornet E, Boue J, Raux-Demay M (1986) First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet 73:358PubMedCrossRef

Pang SY, Murphey W, Levine LS (1982) A pilot newborn screening program for congenital adrenal hyperplasia in Alaska. J Endocrinol Metab 55:413–420CrossRef

Pang SY, Wallace MA, Hofman L (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866PubMed

Reindollar RH, Lewis JB, White PC (1988) Prenatal diagnosis of 21-hydroxylase deficiency by the complementary deoxyribonucleic acid probe for cytochrome P-450C-21OH. Am J Obstet Gynecol 158:545PubMed

Ruppen W, Hagenbuch N, Johr M, Christen P (2003) Cardiac arrest in an infant with congenital adrenal hyperplasia. Acta Anaesthesiol Scand 47:104–105PubMedCrossRef

10.

Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776PubMedCrossRef

11.

Suwa S, Shimozawa K, Kitagawa T (1987) Collaborate study on regional neonatal screening for congenital adrenal hyperplasia in Japan. In: Therell BL (ed) Proceedings of the Sixth International Neonatal Screening Symposium, Excerpta Medica International Congress series 1987. Elsevier, Amsterdam, pp 279–280

12.

White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245PubMedCrossRef

13.

Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI (1995) Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 80:1635PubMed

14.

Witchel SF, Nayak S, Suda-Hartman M (1997) Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis. J Pediatr 131:328PubMed

Title: Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia
Authors: S. Agarwal
G. Deshpande
D. Agarwal
A. Dave
J.J. Shah
Publication date: 01-10-2005
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 5/2005
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-004-0858-3

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2005

Captopril-Induced Pulmonary Infiltrates with Eosinophilia in an Infant with Congenital Heart Disease

Interaction of Antibiotics and Warfarin in Pediatric Cardiology Patients

Successful One-Stage Repair of Unilateral Agenesis of Pulmonary Artery

Administration of Steroids in Pediatric Cardiac Surgery: Impact on Clinical Outcome and Systemic Inflammatory Response

Tetralogy of Fallot with Anomalous Origin of the Right Pulmonary Artery from the Ascending Aorta and Hypoplastic Left Pulmonary Artery

QT Interval Prolongation Associated with the Oral Use of Domperidone in an Infant

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page